Transcriptional rewiring of NF-κB by HBZ and Fra-2 drives inflammatory chemoresistance in Tax-negative adult T-cell leukemia/lymphoma
Julie Tram, Laetitia Marty, Célima Mourouvin, Magali Abrantes, Raymond Césaire, Philippe Hélias, Jean-Michel Mesnard, Véronique Baccini, Jean‐Marie Péloponèse
This study identifies the Fra-2-NF-κB-IL-1β axis as a mechanism driving chemoresistance in Tax-negative ATL, with therapeutic targeting of IL-1 signaling restoring drug sensitivity.
bioRxiv · Oct 1, 2026 · PreprintCancer Biology